Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking.
about
Scalable rule-based modelling of allosteric proteins and biochemical networksThe G protein-coupled receptor heterodimer network (GPCR-HetNet) and its hub componentsMarked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptorsKappa opioid antagonists: past successes and future prospectsG-protein-coupled receptor heteromers: function and ligand pharmacologyKappa-opioid ligands in the study and treatment of mood disorders75 years of opioid research: the exciting but vain quest for the Holy GrailCellular mechanisms of the 5-HT7 receptor-mediated signalingOligomerization of the yeast alpha-factor receptor: implications for dominant negative effects of mutant receptors.Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIPPhysical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activitySeeing the light: preassembly and ligand-induced changes of the interferon gamma receptor complex in cellsPharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid ReceptorsFunctional expression of heteromeric calcitonin gene-related peptide and adrenomedullin receptors in yeast.Beyond desensitization: physiological relevance of arrestin-dependent signaling.Chaperoning G protein-coupled receptors: from cell biology to therapeuticsRole of antibodies in developing drugs that target G-protein-coupled receptor dimers.The differential effects of the gonadotropin receptors on aromatase expression in primary cultures of immature rat granulosa cells are highly dependent on the density of receptors expressed and the activation of the inositol phosphate cascade.Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy.Alterations of CXCR4 function in μ-opioid receptor-deficient glia.Oligomerisation of C. elegans olfactory receptors, ODR-10 and STR-112, in yeast.Hypocretin-1 causes G protein activation and increases ACh release in rat pons.Dopamine receptor-interacting protein 78 acts as a molecular chaperone for CCR5 chemokine receptor signaling complex organization.Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders.Rhodopsin self-associates in asolectin liposomes.Differential response to morphine of the oligomeric state of μ-opioid in the presence of δ-opioid receptorsDesign and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5.HIV-1 coinfection and morphine coexposure severely dysregulate hepatitis C virus-induced hepatic proinflammatory cytokine release and free radical production: increased pathogenesis coincides with uncoordinated host defenses.Heterodimerization of the alpha and beta isoforms of the human thromboxane receptor enhances isoprostane signalingSynthesis of novel triplets with a 1,3,5-trioxazatriquinane skeleton and their pharmacologies for opioid receptors.Morphine induces desensitization of insulin receptor signaling.Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology.Opioid activity of spinally selective analogues of N-naphthoyl-β-naltrexamine in HEK-293 cells and mice.Muscarinic cationic current in gastrointestinal smooth muscles: signal transduction and role in contraction.Imaging of opioid receptors in the central nervous systemG protein coupled receptor structure and activationHeterologous downregulation of vasopressin type 2 receptor is induced by transferrinBiased suppression of TP homodimerization and signaling through disruption of a TM GxxxGxxxL helical interaction motif.Secretin receptor oligomers form intracellularly during maturation through receptor core domains.A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities.
P2860
Q21145330-F09C5054-E5A6-4A67-89BC-01A1D30C947EQ24564171-257A3184-1988-4456-8B0B-DB5B5358EAD1Q24644889-528105FF-8773-42B2-A2AE-A2A1AA58DDD6Q24647830-62DFE9C2-9EA0-46C8-9474-6745A4A2003EQ24653717-544A3F24-3CAA-43D0-88F0-17311444D016Q24657982-45EA45F1-F112-49C2-8230-7ED39057D1A7Q24670315-E50EC772-8DBD-4F1D-AEFA-11C7629D7B39Q26828436-A4B747EB-C71B-4150-BE05-7011C1DFD94EQ27929513-2F71C612-8916-4680-8F14-A33FC1B6907DQ28259947-156AEA0A-8BE6-4D1E-BE46-9E7C6103A2F0Q28283440-E9440712-90FF-4A64-8BBC-793EE9E0BB90Q28646255-7FC9A025-3630-42D4-81ED-EFFC56C7A2E2Q29542291-52EB733C-0D2F-4003-8250-8C75DFEB92F7Q30717334-C08E5469-2894-4D9D-B961-6328FFC137FEQ33890802-EC0711AD-2D62-4D8C-8BC1-A60C06509D39Q33927508-F4817E13-D0AE-44D1-B25E-358B60E52126Q34051430-C6B69D24-233D-4529-B4BF-6801BF19B6B5Q34093067-E3CD7BDD-595C-435E-BFD6-72982EB3696AQ34167249-8391D7DA-4E55-4740-B5D9-794228610474Q34209473-14585565-FD68-4213-97BE-45767F61F5E2Q34257384-A15FA78B-8093-477B-B87C-D012590CA819Q34277180-3FCAC4BE-43C2-4A1F-8215-6DE768CD1ADBQ34344881-D36C306F-E5A6-4E9A-A6D3-D20DE8FAB177Q34425116-28BD477E-8A96-4E41-BE9F-DBB5CF7EDCDDQ34480207-48DBF68E-1A41-4563-B92E-93E39A6FE894Q34767171-9D54B45C-AD21-45C4-B572-15FD3BE16AD6Q35220086-975F9EF1-4442-4999-8BB6-F5A7E1919616Q35531310-FB55589D-4CA7-48B3-88D7-7899754E5E04Q35579014-96CD10EF-E652-428B-A7F7-8B62E202D669Q35627652-E334E402-3090-43F7-9B02-48C965214A8EQ35661518-F7CD3DE5-EEE7-4486-A3FF-B6720AABE6D5Q35693323-42783F81-8C17-47DF-AFB4-1FABBC157DABQ36225640-51742855-342A-4272-85FB-21480C28BC25Q36552092-8ACD8DD7-42F7-4AAF-AC1B-5E09ECDF0894Q36633126-F158F710-CBED-4977-BF47-AC4C7B5312DDQ36692097-993B8A30-9C89-4140-BFE2-6FECCF32834AQ36699899-A8F423E7-3963-49B3-A752-3C70B19C2B5BQ36822598-BA5A3612-0350-4B88-A923-8D277E9FDA92Q36826025-011E89E6-5E63-46C2-928D-30F22BD37133Q36839084-94DC30DA-987D-44D6-B0A3-38776BC5FAE3
P2860
Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Heterodimerization of G-protei ...... gy, signaling and trafficking.
@ast
Heterodimerization of G-protei ...... gy, signaling and trafficking.
@en
Heterodimerization of G-protei ...... gy, signaling and trafficking.
@nl
type
label
Heterodimerization of G-protei ...... gy, signaling and trafficking.
@ast
Heterodimerization of G-protei ...... gy, signaling and trafficking.
@en
Heterodimerization of G-protei ...... gy, signaling and trafficking.
@nl
prefLabel
Heterodimerization of G-protei ...... gy, signaling and trafficking.
@ast
Heterodimerization of G-protei ...... gy, signaling and trafficking.
@en
Heterodimerization of G-protei ...... gy, signaling and trafficking.
@nl
P1476
Heterodimerization of G-protei ...... gy, signaling and trafficking.
@en
P2093
P304
P356
10.1016/S0165-6147(00)01799-5
P577
2001-10-01T00:00:00Z